The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNASA.L Regulatory News (NASA)

  • There is currently no data for NASA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Nasstar plc

27 Jan 2020 13:10

RNS Number : 0336B
Kestrel Partners
27 January 2020
 

FORM 8.3

FORM 8 AMENDMENT

 

The Form 8.3 - Nasstar plc announcement released on 24 January 2020 at 14:27 under RNS No 9032A has been amended.

 

Amendments are identified with an asterisk (*) - SEE 2.A

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Kestrel Partners LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Nasstar plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

23 January 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

117,444,211*

19.05

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

117,444,211

19.05

 

All interests and all short positions should be disclosed.

 

*On 14 January 2020 Kestrel Partners LLP transferred, on behalf of four discretionary clients, 501,745 ordinary shares of 1p each ("Shares") in the Nasstar plc from accounts managed by Kestrel to the clients' broker accounts. This transfer by Kestrel was made at the request of these clients and there is no change in ultimate beneficial ownership.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

27 January 2020

Contact name:

Aneil Bhatt

Telephone number:

+ 44 203 371 6105

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETPPUQUGUPUGWM
Date   Source Headline
19th Jun 20192:58 pmRNSHolding(s) in Company
10th Jun 20194:51 pmRNSResult of AGM
16th May 201912:40 pmRNSPosting of annual report and notice of AGM
30th Apr 20194:30 pmRNSHolding(s) in Company
29th Apr 20197:00 amRNSDirectorate Change
29th Apr 20197:00 amRNSResults for the year to 31 December 2018
15th Apr 20195:22 pmRNSHolding(s) in Company
22nd Mar 20199:11 amRNSHolding(s) in Company
20th Mar 20195:05 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSTrading Statement and Notice of Results
25th Jan 20197:00 amRNSChange of Auditor
14th Nov 20184:08 pmRNSExercise of Options and Total Voting Rights
8th Oct 20187:00 amRNSHolding(s) in Company
1st Oct 20181:24 pmRNSHolding(s) in Company
24th Sep 20182:21 pmRNSReplacement: Interim Results
24th Sep 20187:00 amRNSInterim Results
21st Aug 20187:00 amRNSHolding(s) in Company
20th Aug 20186:31 pmRNSHolding(s) in Company
20th Aug 20185:10 pmRNSHolding(s) in Company
20th Aug 20185:10 pmRNSHolding(s) in Company
30th Jul 20183:55 pmRNSHolding(s) in Company
30th Jul 201811:36 amRNSHolding(s) in Company
30th Jul 20187:00 amRNSTrading Statement
19th Jul 201810:13 amRNSHolding(s) in Company
7th Jun 201812:10 pmRNSResult of AGM
8th May 201810:15 amRNSPosting of Annual Report and Notice of AGM
4th May 20188:24 amRNSHolding(s) in Company
3rd May 20182:02 pmRNSHolding(s) in Company
2nd May 20185:45 pmRNSDirector Dealing
1st May 20187:00 amRNSResults for the year to 31 December 2017
21st Mar 20187:00 amRNSNotice of Results
19th Mar 20184:26 pmRNSHolding(s) in Company
15th Feb 20185:09 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSTrading Statement
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
29th Nov 20171:41 pmRNSDirector/PDMR Shareholding
7th Nov 20177:00 amRNSSignificant Contract Win
25th Sep 20177:00 amRNSInterim Results
20th Sep 20171:34 pmRNSHolding(s) in Company
29th Aug 20174:43 pmRNSHolding(s) in Company
24th Jul 20177:00 amRNSTrading Statement
25th May 201711:19 amRNSResult of AGM and Total Voting Rights
17th May 20177:00 amRNSInterest rate margin reduction
10th May 20179:15 amRNS'1000 Companies to Inspire Britain' Award received
28th Apr 20171:48 pmRNSNotice of AGM & posting of Annual Report
24th Apr 20177:00 amRNSFinal Results
30th Mar 20174:13 pmRNSHolding(s) in Company
30th Mar 201711:49 amRNSHolding(s) in Company
22nd Feb 20177:00 amRNSHolding(s) in Company
31st Jan 20174:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.